424 related articles for article (PubMed ID: 30802618)
1. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
[TBL] [Abstract][Full Text] [Related]
2. Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.
McAvoy S; Ciura K; Wei C; Rineer J; Liao Z; Chang JY; Palmer MB; Cox JD; Komaki R; Gomez DR
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):819-27. PubMed ID: 25220718
[TBL] [Abstract][Full Text] [Related]
3. Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.
Gomez DR; Gillin M; Liao Z; Wei C; Lin SH; Swanick C; Alvarado T; Komaki R; Cox JD; Chang JY
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):665-70. PubMed ID: 23688815
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
[TBL] [Abstract][Full Text] [Related]
5. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
[TBL] [Abstract][Full Text] [Related]
6. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.
Lee SU; Moon SH; Cho KH; Pyo HR; Kim JY; Kim DY; Kim TH; Suh YG; Kim YJ
Strahlenther Onkol; 2016 Sep; 192(9):649-57. PubMed ID: 27282279
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry.
Saeed AM; Khairnar R; Sharma AM; Larson GL; Tsai HK; Wang CJ; Halasz LM; Chinnaiyan P; Vargas CE; Mishra MV
Adv Radiat Oncol; 2020; 5(5):978-983. PubMed ID: 33083661
[TBL] [Abstract][Full Text] [Related]
9. Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis.
Thorpe CS; Niska JR; Girardo ME; Kosiorek HE; McGee LA; Hartsell WF; Larson GL; Tsai HK; Rossi CJ; Rosen LR; Vargas CE
Breast J; 2019 Nov; 25(6):1160-1170. PubMed ID: 31338974
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer.
McAvoy SA; Ciura KT; Rineer JM; Allen PK; Liao Z; Chang JY; Palmer MB; Cox JD; Komaki R; Gomez DR
Radiother Oncol; 2013 Oct; 109(1):38-44. PubMed ID: 24016675
[TBL] [Abstract][Full Text] [Related]
11. High-dose proton beam therapy for stage I non-small cell lung cancer: Clinical outcomes and prognostic factors.
Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Azami Y; Kato T; Tsukiyama I; Hareyama M; Kikuchi Y; Daimon T; Hata M; Inoue T; Fuwa N
Acta Oncol; 2015 Mar; 54(3):307-14. PubMed ID: 25291076
[TBL] [Abstract][Full Text] [Related]
12. Dose escalation study of proton beam therapy with concurrent chemotherapy for stage III non-small cell lung cancer.
Harada H; Fuji H; Ono A; Kenmotsu H; Naito T; Yamashita H; Asakura H; Nishimura T; Takahashi T; Murayama S
Cancer Sci; 2016 Jul; 107(7):1018-21. PubMed ID: 27110950
[TBL] [Abstract][Full Text] [Related]
13. Reirradiation of thoracic cancers with intensity modulated proton therapy.
Ho JC; Nguyen QN; Li H; Allen PK; Zhang X; Liao Z; Zhu XR; Gomez D; Lin SH; Gillin M; Komaki R; Hahn S; Chang JY
Pract Radiat Oncol; 2018; 8(1):58-65. PubMed ID: 28867546
[TBL] [Abstract][Full Text] [Related]
14. Reirradiation With Proton Therapy for Recurrent Malignancies of the Esophagus and Gastroesophageal Junction: Results of the Proton Collaborative Group Multi-Institutional Prospective Registry Trial.
Hotca A; Sindhu KK; Lehrer EJ; Hartsell WF; Vargas C; Tsai HK; Chang JH; Apisarnthanarax S; Nichols RC; Chhabra AM; Hasan S; Press RH; Lazarev S; Hajj C; Kabarriti R; Rule WG; Simone CB; Choi JI
Adv Radiat Oncol; 2024 May; 9(5):101459. PubMed ID: 38596455
[TBL] [Abstract][Full Text] [Related]
15. Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer.
Chao HH; Berman AT; Simone CB; Ciunci C; Gabriel P; Lin H; Both S; Langer C; Lelionis K; Rengan R; Hahn SM; Prabhu K; Fagundes M; Hartsell W; Mick R; Plastaras JP
J Thorac Oncol; 2017 Feb; 12(2):281-292. PubMed ID: 27826034
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
[TBL] [Abstract][Full Text] [Related]
17. Central Airway Toxicity After High Dose Radiation: A Combined Analysis of Prospective Clinical Trials for Non-Small Cell Lung Cancer.
Wang W; Matuszak MM; Hu C; Huang KC; Chen E; Arenberg D; Curtis JL; Jolly S; Jin JY; Machtay M; Ten Haken RK; Kong FS
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):587-596. PubMed ID: 32470501
[TBL] [Abstract][Full Text] [Related]
18. High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: results of a 12-year experience at Loma Linda University Medical Center.
Bush DA; Cheek G; Zaheer S; Wallen J; Mirshahidi H; Katerelos A; Grove R; Slater JD
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):964-8. PubMed ID: 23845845
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated proton beam therapy for centrally located lung cancer.
Nakamura N; Hotta K; Zenda S; Baba H; Kito S; Akita T; Motegi A; Hojo H; Nakamura M; Parshuram RV; Okumura M; Akimoto T
J Med Imaging Radiat Oncol; 2019 Aug; 63(4):552-556. PubMed ID: 31145553
[TBL] [Abstract][Full Text] [Related]
20. Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer.
Boyce-Fappiano D; Nguyen QN; Chapman BV; Allen PK; Gjyshi O; Pezzi TA; De B; Gomez D; Lin SH; Chang JY; Liao Z; Lee P; Gandhi SJ
Clin Lung Cancer; 2021 Sep; 22(5):e745-e755. PubMed ID: 33707003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
